Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.

Alibhai SM, Mohamedali HZ, Gulamhusein H, Panju AH, Breunis H, Timilshina N, Fleshner N, Krahn MD, Naglie G, Tannock IF, Tomlinson G, Warde P, Duff Canning S, Cheung AM.

Osteoporos Int. 2013 Oct;24(10):2571-9. doi: 10.1007/s00198-013-2343-4. Epub 2013 Apr 6.

PMID:
23563932
2.

Policy alternatives for treatments for rare diseases.

Panju AH, Bell CM.

CMAJ. 2010 Nov 23;182(17):E787-92. doi: 10.1503/cmaj.081429. Epub 2010 Jul 12. No abstract available.

3.

Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.

Panju AH, Breunis H, Cheung AM, Leach M, Fleshner N, Warde P, Duff-Canning S, Krahn M, Naglie G, Tannock I, Tomlinson G, Alibhai SM.

BJU Int. 2009 Mar;103(6):753-7. doi: 10.1111/j.1464-410X.2008.08156.x. Epub 2008 Oct 24.

4.

Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia.

Panju AH, Danesh A, Minden MD, Kelvin DJ, Alibhai SM.

Support Care Cancer. 2009 May;17(5):539-46. doi: 10.1007/s00520-008-0512-3. Epub 2008 Oct 18.

PMID:
18931862

Supplemental Content

Loading ...
Support Center